Deutsche Borse AG:企業のM&A・事業提携・投資動向

◆英語タイトル:Deutsche Borse AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1398
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:78
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Deutsche Borse AG – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Deutsche Borse AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Deutsche Borse AG since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Deutsche Borse AG’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Deutsche Borse AG. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Deutsche Borse AG’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Deutsche Borse AG and its subsidiaries since 2007.
- Information about key financial and legal advisors for Deutsche Borse AG’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Deutsche Borse AG’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 24
Corporate Venturing – Overview 24
Corporate Venturing – Deal reports 25
PARTNERSHIP 39
Partnership – Overview 39
Partnership – Deal reports 40
DIVESTMENTS 46
Divestments – Overview 46
Divestments – Deal reports 47
APPENDIX 68
Contact Us 68
About MarketLine Financial Deals Database 68
Deal Definition and Methodology 70
About MarketLine 77

List of Tables
Table 1: Deutsche Borse AG M&A volume and value trend (2014-YTD2018)
Table 2: Deutsche Borse AG M&A activity by geography (2014-YTD2018)
Table 3: Deutsche Borse AG corporate venturing volume and value trend (2014-YTD2018)
Table 4: Deutsche Borse AG corporate venturing by geography (2014-YTD2018)
Table 5: Deutsche Borse AG partnership volume and value trend (2014-YTD2018)
Table 6: Deutsche Borse AG partnership trend by key deal type (2014-YTD2018)
Table 7: Deutsche Borse AG divestments volume and value trend (2014-YTD2018)
Table 8: Deutsche Borse AG divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Deutsche Borse AG M&A volume and value trend (2014-YTD2018)
Figure 2: Deutsche Borse AG M&A activity by geography (2014-YTD2018)
Figure 3: Deutsche Borse AG corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Deutsche Borse AG corporate venturing by geography (2014-YTD2018)
Figure 5: Deutsche Borse AG partnership volume and value trend (2014-YTD2018)
Figure 6: Deutsche Borse AG partnership trend by key deal type (2014-YTD2018)
Figure 7: Deutsche Borse AG divestments volume and value trend (2014-YTD2018)
Figure 8: Deutsche Borse AG divestments by geography (2014-YTD2018)

★海外企業調査レポート[Deutsche Borse AG:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Central Alabama Electric Cooperative Inc:企業の戦略的SWOT分析
    Central Alabama Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Hindustan ZInc Ltd:企業の戦略・SWOT・財務分析
    Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Minoryx Therapeutics sl:製薬・医療:M&Aディール及び事業提携情報
    Summary Minoryx Therapeutics sl (Minoryx) is a clinical stage biotechnology company that develops treatments for life threatening rare diseases. The company offers discovery, preclinical research, development and clinical trial programs. It develops ALD-MIN, morquio B and PCT drugs used for lysosoma …
  • PIQUR Therapeutics AG-製薬・医療分野:企業M&A・提携分析
    Summary PIQUR Therapeutics AG (PIQUR) is a clinical-stage pharmaceutical company that discovers and develops anti-cancer drugs. The company develops innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibitior for the treatment of cancer and inflammatory diseases. Its pipe …
  • Extendicare Inc (EXE):企業の財務・戦略的SWOT分析
    Summary Extendicare Inc (Extendicare), formerly Crownx Inc is a healthcare service provider that offers long-term care services. The center’s services include short stay care, convalescent care, home health care, group purchasing, assisted living, retirement living, workplace health and wellness, sk …
  • Infinity Pharmaceuticals Inc (INFI):企業の財務・戦略的SWOT分析
    Infinity Pharmaceuticals Inc (INFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Solstad Farstad ASA (SOFF):石油・ガス:M&Aディール及び事業提携情報
    Summary Solstad Farstad ASA (Solstad), formerly Solstad Offshore ASA is an oil and gas company that provides vessel operation solutions. The company offers carbon footprint, climate neutral network, offshore shipping, green operations, and rainforest protection, documentation programs, and others. I …
  • New Look Retail Group Limited:企業の戦略・SWOT・財務情報
    New Look Retail Group Limited - Strategy, SWOT and Corporate Finance Report Summary New Look Retail Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • E*Trade Financial Corp:企業の戦略・SWOT・財務情報
    E*Trade Financial Corp - Strategy, SWOT and Corporate Finance Report Summary E*Trade Financial Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • EKF Diagnostics Holdings Plc (EKF):医療機器:M&Aディール及び事業提携情報
    Summary EKF Diagnostics Holdings Plc (EKF Diagnostics) is a medical device company that designs, develops, manufactures, and commercializes point-of-care (POC) devices and tests and chemical reagents used for manufacturing in central laboratories. Its POC range includes hemoglobin analyzers, glucose …
  • Fujirebio Diagnostics Inc:企業の製品パイプライン分析2018
    Summary Fujirebio Diagnostics Inc (FDI), a subsidiary of Fujirebio Inc is a healthcare diagnostic company that manufactures, markets and develops biomarker assays and in-vitro diagnostic products. The company’s products include OEM custom solutions, manual kits, serum products, multi-constituent con …
  • Avantium NV (AVTX):企業の財務・戦略的SWOT分析
    Avantium NV (AVTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • AMTEC Corporation:企業の戦略・SWOT・財務情報
    AMTEC Corporation - Strategy, SWOT and Corporate Finance Report Summary AMTEC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Bsquare Corporation (BSQR):企業の財務・戦略的SWOT分析
    Bsquare Corporation (BSQR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Innovation Pharmaceuticals Inc (IPIX)-製薬・医療分野:企業M&A・提携分析
    Summary Innovation Pharmaceuticals Inc (Innovation Pharmaceuticals), formerly Cellceutix Corp is a biopharmaceutical company that offers discovering and advancing innovative medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications. The company offers kevetrin for t …
  • Adamis Pharmaceuticals Corp (ADMP)-医療機器分野:企業M&A・提携分析
    Summary Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc is a biopharmaceutical company that offers therapies. The company develops and commercializes products in the therapeutic areas of allergy and respiratory diseases. Its pipeline product, epinephrine pre-filled syringe …
  • Intec Pharma ltd (NTEC):企業の財務・戦略的SWOT分析
    Summary Intec Pharma Ltd (Intec Pharma) is a biopharmaceutical company that offers delivery solutions for drugs. The company’s pipeline products include drug indications for Parkinson’s disease, insomnia and other diseases. Its proprietary gastro retentive formulation, offers a drug delivery solutio …
  • Collegium Pharmaceutical Inc (COLL):企業の財務・戦略的SWOT分析
    Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Parkway Pantai Ltd:企業の戦略的SWOT分析
    Parkway Pantai Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Votorantim Energia Ltda:企業の戦略的SWOT分析
    Votorantim Energia Ltda - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆